A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma

Clinical trial NCT04740034 · TERMINATED

Trial details

NCT number: NCT04740034
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer

Start date: 2021-04-29
Primary completion: 2024-06-24
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.